HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sunset Natural Injunction Continues Rise In DoJ Supplement GMP Complaints

This article was originally published in The Tan Sheet

Executive Summary

After litigating six civil complaints in 2014, DoJ’s uptick in bringing criminal and civil cases concerning supplement GMP violations in 2015 comes with the industry’s Senate champions, Orrin Hatch, R-Utah, and Martin Heinrich, D-NM, urging prosecutions against marketers of spiked products.

You may also be interested in...



Enforcement Roundup: Daniel Chapter One, Peanut Corp. Of America

Final chapter for Daniel Chapter One owner; prison sentence for head of salmonella-tainted peanut firm.

Industry Roundup: SEC Fines MJN, Criminal Charge For Herbals Seller, Decree Closes Aspen Supplement Marketer

FCPA violations cost Mead Johnson $12M; decree closes Aspen supplement marketer; equity funding for SmartyPants; homeopathic online retailer warned; ForeverGreen launches strong; and more news in brief.

Senators Push Park Doctrine Prosecution For Spiked Supplement ‘Criminal Endeavors’

Key industry allies say they are “deeply concerned” about “blatant criminal activity” in products marketed as supplements but containing anabolic steroids or other drugs. “Bring a few of these actions and you scare people into the idea that … you could actually go to jail,” says attorney Frederick Stearns.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

RS123335

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel